BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37553529)

  • 1. New insights into APOBEC-mediated mutagenesis in prostate cancer.
    Masone MC
    Nat Rev Urol; 2023 Sep; 20(9):519. PubMed ID: 37553529
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitochondrial mutagenesis and oxidative stress in human prostate cancer.
    Chen JZ; Kadlubar FF
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):1-12. PubMed ID: 15845219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
    Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
    Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to Alexander Yang, Vincent L. Cannataro, Jeffrey P. Townsend's Letter to the Editor, re: Ming-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al. APOBEC-mediated Mutagenesis as, a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer. Eur Urol 2019, 76:9-13.
    Shi MJ; Meng XY; Chen CL; Dyrskjøt L; Radvanyi F; Prokunina-Olsson L; Bernard-Pierrot I
    Eur Urol; 2020 Jan; 77(1):e26-e27. PubMed ID: 31493961
    [No Abstract]   [Full Text] [Related]  

  • 6. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
    Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
    Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma.
    Faden DL; Kuhs KAL; Lin M; Langenbucher A; Pinheiro M; Yeager M; Cullen M; Boland JF; Steinberg M; Bass S; Lewis JS; Lawrence MS; Ferris RL; Mirabello L
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection.
    Chen JZ; Gokden N; Greene GF; Mukunyadzi P; Kadlubar FF
    Cancer Res; 2002 Nov; 62(22):6470-4. PubMed ID: 12438238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.
    DiMarco AV; Qin X; McKinney BJ; Garcia NMG; Van Alsten SC; Mendes EA; Force J; Hanks BA; Troester MA; Owzar K; Xie J; Alvarez JV
    Cancer Immunol Res; 2022 Jan; 10(1):70-86. PubMed ID: 34795033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
    Shi R; Wang X; Wu Y; Xu B; Zhao T; Trapp C; Wang X; Unger K; Zhou C; Lu S; Buchner A; Schulz GB; Cao F; Belka C; Su C; Li M; Shu Y
    Theranostics; 2022; 12(9):4181-4199. PubMed ID: 35673559
    [No Abstract]   [Full Text] [Related]  

  • 11. APOBEC mediated mutagenesis drives genomic heterogeneity in endometriosis.
    Revathidevi S; Nakaoka H; Suda K; Fujito N; Munirajan AK; Yoshihara K; Enomoto T; Inoue I
    J Hum Genet; 2022 Jun; 67(6):323-329. PubMed ID: 35017684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.
    Trobridge GD
    Methods Mol Biol; 2019; 1907():103-114. PubMed ID: 30542994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated insights into genetic contribution to prostate cancer predisposition: focus on HOXB13.
    Isaacs WB; Cooney KA; Xu J
    Can J Urol; 2019 Oct; 26(5 Suppl 2):12-13. PubMed ID: 31629417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis.
    Chen JZ; Gokden N; Greene GF; Green B; Kadlubar FF
    Carcinogenesis; 2003 Sep; 24(9):1481-7. PubMed ID: 12869417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
    Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
    Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy.
    Mossanen M; Carvalho FLF; Muralidhar V; Preston MA; Reardon B; Conway JR; Curran C; Freeman D; Sha S; Sonpavde G; Hirsch M; Kibel AS; Van Allen EM; Mouw KW
    Eur Urol; 2022 May; 81(5):466-473. PubMed ID: 34953602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC-Induced Mutagenesis in Cancer.
    Mertz TM; Collins CD; Dennis M; Coxon M; Roberts SA
    Annu Rev Genet; 2022 Nov; 56():229-252. PubMed ID: 36028227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.
    Gerhauser C; Favero F; Risch T; Simon R; Feuerbach L; Assenov Y; Heckmann D; Sidiropoulos N; Waszak SM; Hübschmann D; Urbanucci A; Girma EG; Kuryshev V; Klimczak LJ; Saini N; Stütz AM; Weichenhan D; Böttcher LM; Toth R; Hendriksen JD; Koop C; Lutsik P; Matzk S; Warnatz HJ; Amstislavskiy V; Feuerstein C; Raeder B; Bogatyrova O; Schmitz EM; Hube-Magg C; Kluth M; Huland H; Graefen M; Lawerenz C; Henry GH; Yamaguchi TN; Malewska A; Meiners J; Schilling D; Reisinger E; Eils R; Schlesner M; Strand DW; Bristow RG; Boutros PC; von Kalle C; Gordenin D; Sültmann H; Brors B; Sauter G; Plass C; Yaspo ML; Korbel JO; Schlomm T; Weischenfeldt J
    Cancer Cell; 2018 Dec; 34(6):996-1011.e8. PubMed ID: 30537516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.
    Zhang Y; Delahanty R; Guo X; Zheng W; Long J
    Hum Genomics; 2015 Dec; 9():34. PubMed ID: 26682542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of gene expression and mutation data points on contribution of transcription to the mutagenesis by APOBEC enzymes.
    Chervova A; Fatykhov B; Koblov A; Shvarov E; Preobrazhenskaya J; Vinogradov D; Ponomarev GV; Gelfand MS; Kazanov MD
    NAR Cancer; 2021 Sep; 3(3):zcab025. PubMed ID: 34316712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.